1. Home
  2. EBON vs NXL Comparison

EBON vs NXL Comparison

Compare EBON & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ebang International Holdings Inc.

EBON

Ebang International Holdings Inc.

N/A

Current Price

$2.34

Market Cap

19.5M

Sector

Technology

ML Signal

N/A

Logo Nexalin Technology Inc.

NXL

Nexalin Technology Inc.

N/A

Current Price

$0.43

Market Cap

8.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EBON
NXL
Founded
2010
2010
Country
China
United States
Employees
N/A
7
Industry
Semiconductors
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.5M
8.3M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
EBON
NXL
Price
$2.34
$0.43
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
4.0K
249.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$38.28
Revenue Next Year
N/A
$185.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.30
$0.37
52 Week High
$5.90
$2.57

Technical Indicators

Market Signals
Indicator
EBON
NXL
Relative Strength Index (RSI) 35.21 39.12
Support Level $2.30 $0.39
Resistance Level $3.76 $0.62
Average True Range (ATR) 0.18 0.04
MACD 0.01 0.00
Stochastic Oscillator 5.56 11.05

Price Performance

Historical Comparison
EBON
NXL

About EBON Ebang International Holdings Inc.

Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Share on Social Networks: